Medtronic InFuse for cervical spine
This article was originally published in The Gray Sheet
Executive Summary
Firm will conduct a trial of its InFuse bone graft in cervical spinal fusion after being granted an investigational device exemption from FDA, Medtronic announces Oct. 13. The bone graft will be used inside a polyetheretherketone (PEEK) polymer interbody spacer with a cervical plate. According to Medtronic, 200,000 spinal fusion procedures for the cervical spine are conducted in the U.S. each year. InFuse is approved to treat open tibia fractures and for anterior lumbar interbody fusion procedures. The firm also is pursuing approval for InFuse in posterior lumbar fusion and oral maxillofacial procedures...
You may also be interested in...
FDA panel to review Medtronic’s InFuse
Bone graft for oral maxillofacial procedures will go before agency's Dental Products Panel Nov. 9 in Gaithersburg, Md., according to the Oct. 26 Federal Register. Infuse contains the recombinant human bone morphogenetic protein rhBMP-2 - a "genetically engineered version of a naturally occurring protein ... capable of initiating bone growth," Medtronic says. InFuse also is being studied under an investigational device exemption for use in cervical spinal fusion (1"The Gray Sheet" Oct. 16, 2006, In Brief)...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.